Extensively drug-resistant tuberculosis in India: A review

Indian Journal of Medical Research

Volumn 136, Issue 4, 2012, Pages 599-604

  Michael, Joy Sarojini ^a   Jacob John, T ^a  

^a CHRISTIAN MEDICAL COLLEGE   (India)

Author keywords

Extensively drug resistant tuberculosis; India; MDR TB; XDR TB

Indexed keywords

BACTERIUM CULTURE; BACTERIUM ISOLATE; DRUG RESISTANT TUBERCULOSIS; HEALTH SURVEY; HUMAN; INDIA; NONHUMAN; REVIEW; TERTIARY HEALTH CARE;

EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HUMANS; INDIA; PUBMED; TERTIARY CARE CENTERS;

EID: 84869022703     PISSN: 09715916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (31)

1. Centers for Disease Control and Prevention. Revised definition of extensively drug resistant tuberculosis. Morb Mortal Weekly Rep 2006; 55: 1176.
2. World Health Organization. Extensively drug resistant tuberculosis (XDR TB): recommendations for prevention and control. Wkly Epidemiol Rec 2006; 81: 430-2.
3. World Health Organization. Multidrug and extensively drug-resistant tuberculosis: global report on surveillance and response. Geneva, Switzerland: World Health Organization; 2010.
4. Thomas A, Ramachandran R, Rehaman F, Jaggarajamma K, Santha T, Selvakumar N, et al. Management of multidrug resistance tuberculosis in the field: Tuberculosis Research Centre experience. Indian J Tuberc 2007; 54: 117-24.
5. Ramachandran R, Nalini S, Chandrasekar V, Dave PV, Sanghvi AS, Wares F, et al. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India. Int J Tuberc Lung Dis 2009; 13: 1154-60.
6. Sood OP, Sharma SK. Challenges of MDR/XDR Tuberculosis in India. Proceedings of Round Table Conference Series No. 22. December 2008. New Delhi, India: Ranbaxy Science Foundation; 2008.
7. Jose L, Mundayoor M, Ajaykumar R. Annual Report of the Rajiv Gandhi Centre for Biotechnology, Thiruvananthapuram. Thiruvananthapuram: RGCB; 2007. p. 220.
8. Bikram DS, Hassan G, Kadri SM, Qureshi W, Kamili MA, Singh H, et al. Multidrug-resistant and extensively drug resistant tuberculosis in Kashmir, India. J Infect Dev Ctries 2010; 4: 19-23.
9. Singh S, Sankar MM, Gopinath K. High rate of extensively drug-resistant tuberculosis in Indian AIDS patients. AIDS 2007; 21: 2345-7.
10. Sharma SK, George N, Kadhiravan T, Saha PK, Mishra HK, Hanif M, et al. Prevalence of extensively drug-resistant tuberculosis among patients with multi-drug resistant tuberculosis: a retrospective hospital-based study. Indian J Med Res 2009; 130: 392-5.
11. Dhingra VK, Malik S, Hanif M, Arora VK. XDR tuberculosis: A report from the New Delhi tuberculosis centre, India. J Coll Physicians Surg Pak 2009; 19: 133-5.
12. Jain S, Rodrigues C, Mehta A, Udwadia ZF. High prevalence of XDR-TB from a tertiary care hospital in India. In: Proceedings of the American Thoracic Society International Conference, May 2007. San Francisco, USA; Abstract A510.
13. Rodrigues C. XDR TB-Perspectives from a Referral Tertiary care Hospital in Mumbai. In: Sood OP, Sharma SK, editors. Challenges of MDR/XDR tuberculosis in India. Proceedings of Round Table Conference Series. (22). Ranbaxy Science Foundation, New Delhi, India. December 2008; p. 39-42.
14. Mondal R, Jain A. Extensively drug-resistant Mycobacterium tuberculosis, India. Emerg Infect Dis 2007; 13: 1429-31.
15. Chakraborty N, De C, Bhattacharyya S, Mukherjee A, Santra S, Banerjee D, et al. Drug susceptibility profile of Mycobacterium tuberculosis isolated from HIV infected and uninfected pulmonary tuberculosis patients in eastern India. Trans R Soc Trop Med Hyg 2010; 104: 195-201.
16. Rajasekaran S, Chandrasekar C, Mahilmaran A, Kanakaraj K, Karthikeyan DS, Suriakumar J. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients-a trend. J Indian Med Assoc 2009; 107: 281-2, 284-6.
17. James P, Gupta R, Christopher DJ, Thankagunam B, Veeraraghaven B. MDR-and XDR-TB among suspected drug-resistant TB patients in a tertiary care hospital in India. Clin Respir J 2011; 5: 19-25.
18. Balaji V, Daley P, Anand AA, Sudarsanam T, Michael JS, Sahni RD, et al. Risk factors for MDR and XDR-TB in a tertiary referral hospital in India. PLoS One 2010; 5: e9527.
19. Michael JS, Shalini BE, Mathews MS. Drug Resistant Tuberculosis-An Experience of Southern States of India. Sood OP, Sharma SK, editors. Challenges of MDR/XDR tuberculosis in India. Proceedings of Round Table Conference Series (22). Ranbaxy Science Foundation, New Delhi, India; December 2008. p. 35-8.
20. Paramasivan CN, Rehman F, Wares F, Sundar Mohan N, Sundar S, Devi S, et al. First-and second-line drug resistance patterns among previously treated tuberculosis patients in India. Int J Tuberc Lung Dis 2010; 14: 243-6.
21. Myneedu VP, Visalakshi P, Verma AK, Behera D, Bhalla M. Prevalence of XDR TB cases-A retrospective study from a tertiary care TB hospital. Indian J Tuberc 2011; 58: 54-9.
22. Laszlo A, Rahman M, Espinal M, Raviglione M. Quality assurance programme for drug susceptibility testing Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998. Int J Tuberc Lung Dis 2002. 748-56.
23. Jesudason MV, Mukundan U, Ohri VC, Badrinath S, John TJ. external quality assessment service in Microbiology in India: A six-year experience. Indian J Med Microbiol 2001;: 20-5.
24. Mitnick CD, Shin SS, Seung KJ, Rich ML, Atwood SS, Furin JJ, et al. Comprehensive treatment of extensively drug-resistant tuberculosis. N Engl J Med 2008; 359: 563-74.
25. Gandhi NR, Shah NS, Andrews JR, Vella V, Moll AP, Scott et al. HIV coinfection in multidrug-and extensively drug-resistant tuberculosis results in high early mortality. Am J Respir Crit Care Med 2010; 181: 80-6.
26. James P, Christopher DJ, Balamugesh T, Gupta R. Death of a health care worker with nosocomial extensively drug-resistant tuberculosis in India. Int J Tuberc Lung Dis 2009; 13: 795-6.
27. John TJ, John SM. Paradigm shift for tuberculosis control in high prevalence countries. Trop Med Int Health 2009; 14: 1428-30.
28. John TJ, Vashishtha VM, John SM, Sudarsanam TD. Tuberculosis control must be scientifically defined and soundly designed. Indian J Med Res 2010; 132: 4-8.
29. Steingart KR, Henry M, Viviene NG, Hopewell PC, Ramsay Cunningham J, et al. Fluorescence versus conventional sputum smear microscopy for tuberculosis: a systematic review. Lancet Infect Dis 2006; 6: 570-81.
30. John TJ. Extensively drug-resistant tuberculosis in India. Indian J Med Res 2010; 131: 109-10.
31. Central TB Division. TB India 2010. DOTS-Plus guidelines. Central TB Division, Directorate General of Health Services, Ministry of Health & Family Welfare, Nirman Bhavan, New Delhi, 2010. Revised National TB Control Programme. India. Available from: http://www.tbcindia.org, accessed on August 2011.